China Deal Monitor: Intel Capital leads $14m Series B round in KFBIO and more updates

China Deal Monitor: Intel Capital leads $14m Series B round in KFBIO and more updates

Ningbo-headquartered biotech company Konfoong Biotech International Co.,Ltd (KFBIO) has  announced the completion of as much as 100 million yuan ($14 million) in its Series B round of financing, per a company statement on Thursday. It was led by Intel Capital, an investment vehicle of Intel Corporation focused on emerging technology companies globally.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter